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S U M M A R Y
Objectives: Hypoglycorrhachia (cerebrospinal ﬂuid (CSF) glucose <45 mg/dl) has been identiﬁed as a
prognostic factor in patients with meningitis. The differential diagnosis of hypoglycorrhachia and its
clinical signiﬁcance was analyzed in the present study.
Methods: This was a retrospective study of 620 adult patients with community-acquired meningitis (CSF
white blood cell count >5  106 cells/l and absence of a CSF shunt or recent neurosurgical procedure (<1
month)) at eight Memorial Hermann hospitals in Houston, Texas, from January 2005 to December
2010. An adverse clinical outcome was deﬁned as a Glasgow outcome scale score of 4.
Results: Out of 620 patients with meningitis, 116 (19%) had hypoglycorrhachia. Etiologies of
hypoglycorrhachia were idiopathic (n = 40), bacterial (n = 27), cryptococcal (n = 26), viral (n = 15),
and tuberculous (n = 4). Patients with hypoglycorrhachia were more likely to be immunosuppressed,
have a history of intravenous drug use, and present with a vesicular or petechial rash, nausea or
vomiting, nuchal rigidity, sinusitis/otitis, abnormal mental status, and focal neurological deﬁcits
compared to those patients without hypoglycorrhachia (p < 0.05). Additionally, patients in the
hypoglycorrhachia group had signiﬁcantly higher rates of positive CSF and blood cultures, urgent
treatable conditions, and abnormal cranial imaging (p < 0.05). Furthermore, patients with hypoglycor-
rhachia had more adverse clinical outcomes (26/116 (22.4%) vs. 45/504 (8.9%); p < 0.001).
Conclusion: Hypoglycorrhachia has signiﬁcant clinical and prognostic value in the evaluation of adult
patients with community-acquired meningitis.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Hypoglycorrhachia is deﬁned as a cerebrospinal ﬂuid (CSF)
glucose level of <45 mg/dl or a CSF to serum glucose ratio 0.5, and
occurs secondary to glycolysis by bacteria or leukocytes, and/or by
altered glucose transport.1,2 In order to have a reliable CSF to serum
glucose ratio, the two determinations should be done within 60 min
of each other.3 Hypoglycorrhachia is usually suggestive of bacterial,
tuberculous, and fungal meningitis, but has been reported in other
cases such as in viral/aseptic meningitis,4–7 leptomeningeal
carcinomatosis,8 subarachnoid hemorrhage,9 Lyme meningitis,10
neurobrucellosis,11 and neurosarcoidosis.12 The only study to our
knowledge that has evaluated the differential diagnosis of* Corresponding author. Tel.: +1 713 500 7140; fax: +1 713 500 5495.
E-mail address: Rodrigo.Hasbun@uth.tmc.edu (R. Hasbun).
http://dx.doi.org/10.1016/j.ijid.2015.08.001
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).hypoglycorrhachia was done in children and published in 1976 be-
fore the advent of molecular diagnostic tests.13
The purpose of this study was to determine the differential
diagnosis of hypoglycorrhachia and its signiﬁcance in adults with
community-acquired meningitis and to evaluate the reliability of
the CSF to serum glucose ratio.
2. Methods
2.1. Case deﬁnition
A case was deﬁned as a patient aged >16 years with symptoms
of community-acquired meningitis (fever, headache, stiff neck,
altered mental status, or focal neurological symptoms) and a CSF
white blood cell (WBC) count of >5  106 cells/l, presenting to the
emergency department at eight Memorial Hermann hospitals in
Houston, Texas and surrounding areas between January 2005 andciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
V. Shrikanth et al. / International Journal of Infectious Diseases 39 (2015) 39–4340December 2010. The study was approved by the University of
Texas Health in Houston Committee for the Protection of Human
Subjects and the Memorial Hermann Hospital Research Review
Committee.
2.2. Data collection and laboratory testing
Baseline data were obtained at ‘time zero’, deﬁned as the time of
the emergency department visit. Baseline information including
patient demographics, signiﬁcant comorbid conditions measured
by Charlson comorbidity scale,14 immunosuppression and HIV/
AIDS, presenting signs and symptoms including the Glasgow coma
scale (GCS) score,15 laboratory values, and imaging results
including computed tomography (CT) scans of the head and
magnetic resonance imaging (MRI) of the brain, were obtained. The
imaging results were read by board-certiﬁed radiologists at the
various Memorial Hermann hospitals and considered abnormal in
the presence of parenchymal abnormalities excluding cerebral
atrophy. Concomitant sinusitis was not considered as an abnor-
mality. The management decisions and outcomes were obtained
and all data were accessed from patient medical records
maintained in either paper or electronic form. Etiologies of the
episodes of meningitis were divided into four categories: (1)
unknown cause, (2) untreatable cause, (3) treatable but non-
urgent cause, and (4) treatable and urgent cause.
Hypoglycorrhachia was deﬁned as a CSF glucose <45 mg/dl.1
The time between the serum glucose and the CSF glucose
determination was considered concomitant if less than 60 min.3
An adverse clinical outcome at the time of discharge was
determined using the Glasgow outcome scale (GOS).16 An adverse
clinical outcome was deﬁned as a GOS score of 1–4, where a score
of 1 indicates death, a score of 2 indicates a vegetative state
(deﬁned as an inability to interact with the environment), a score
of 3 indicates severe disability (deﬁned as an inability to live
independently but following commands), a score of 4 indicatesTable 1
Baseline characteristics and clinical manifestations of 620 adults with community-acq
Variable CSF glucose <45 mg/
(n = 116)
Age, years, median (range) 42 (18–92) 
Sex, female, n (%) 64/116 (55.1) 
Ethnicity, n (%) 
White 52/116 (44.8) 
African American 32/116 (27.5) 
Hispanic 29/116 (25) 
Asian 3/116 (2.5) 
Uninsured, n (%) 36/115 (31.3) 
Coexisting medical conditions, n (%)
Charlson comorbidity index score >1 21/116 (18.1) 
Immunosuppressed 4/115 (3.5) 
HIV/AIDS 30/115 (26.1) 
History of intravenous drug use 6/113 (5.3) 
Presenting symptoms and signs, n (%)
Headache 93/110 (84.5) 
Nausea or vomiting 64/107 (59.8) 
Photophobia 34/98 (34.6) 
Stiff neck 52/109 (47.7) 
Fever 64/115 (55.6) 
Malaise 46/107 (42.9) 
Respiratory symptoms 19/109 (17.4) 
Nuchal rigidity 44/95 (46.3) 
Sinusitis/otitis 18/116 (15.5) 
Abnormal mental statusb 31/112 (27.6) 
Focal neurological deﬁcitsc 19/111 (17.1) 
Seizure within 1 week of presentation 4/114 (3.5) 
Skin rash 3/109 (2.7) 
CSF, cerebrospinal ﬂuid.
a p-Value comparing the hypoglycorrhachia and non-hypoglycorrhachia groups.
b Disorientation or Glasgow coma scale score <15.
c Focal motor deﬁcit, cranial nerve abnormality, or aphasia.moderate disability (deﬁned as an inability to return to work or
school but retaining the ability to live independently), and a score
of 5 indicates mild or no disability (where the patient is able to
return to work or school).
2.3. Statistical analysis
Patients with meningitis were divided into hypoglycorrhachia
and non-hypoglycorrhachia groups and bivariate analyses were
performed using Fisher’s exact test, the Chi-square test, and the
Student t-test.
3. Results
3.1. Cohort assembly
After screening 727 patients with meningitis, 107 were
excluded for the following reasons: presence of a ventricular
peritoneal shunt (n = 24) or post-craniotomy meningitis (n = 17);
received oral antibiotics before lumbar puncture, were treated
with intravenous antibiotics for more than 48 h, and had no
identiﬁable etiology (n = 32); and incomplete medical records
(n = 34). Therefore, a total of 620 patients were enrolled and
divided into hypoglycorrhachia (n = 116) and non-hypoglycor-
rhachia (n = 504) groups.
3.2. Baseline characteristics and laboratory ﬁndings
Patients in the hypoglycorrhachia group were older, had
more co-existing otitis media, sinusitis, and immunosuppres-
sion, and had higher rates of nuchal rigidity, vesicular or
petechial rash, abnormal mental status, and focal neurological
deﬁcits than those in the non-hypoglycorrhachia group
(p < 0.005) (Table 1). In regards to HIV/AIDS, there were
26.1% cases in the hypoglycorrhachia group and 7.5% in theuired meningitis
dl CSF glucose >45 mg/dl
(n = 504)
p-Valuea
36 (18–92) 0.013
266/504 (52.7) 0.612
0.960
235/504 (46.6)
138/504 (27.4)
117/504 (23.2)
16/504 (3.2)
157/504 (31.2) 0.013
58/504 (11.5) 0.053
16/504 (3.2) 0.000
38/504 (7.5) 0.000
7/502 (1.4) 0.000
455/491 (92.6) 0.013
339/487 (69.6) 0.026
184/445 (41.3) 0.292
213/480 (44.3) 0.761
323/498 (64.8) 0.153
179/482 (37.1) 0.228
54/488 (11.1) 0.090
135/480 (28.1) <0.001
22/503 (4.3) <0.001
86/504 (17.1) <0.001
25/501 (4.9) <0.001
22/503 (4.3) 0.431
135/480 (28.1) 0.001
Table 2
Laboratory data of 620 adult patients with community-acquired meningitis with and without hypoglycorrhachia
Variable CSF glucose <45 mg/dl
(n = 116)
CSF glucose >45 mg/dl
(n = 504)
p-Value
Laboratory results, median (range)
Serum leukocyte count, 109 cells/l 8.4 (1.5–43.5) 8.8 (0.9–42.0) 0.113
CSF leukocyte count, 106 cells/l 258 (5–53 600) 128 (6–11 500) <0.001
CSF protein, mg/dl 147 (41–599) 71 (18–706) <0.001
CSF glucose, mg/dl 32 (1–44) 58 (45–421) <0.001
Serum glucose, mg/dl 112 (64–260) 110 (72–1042) 0.327
Serum hypoglycemiaa, n (%) 0/114 (0.0) 0/505 (0.0) -
Positive CSF culture, n (%) 21/112 (18.7)b 13/495 (2.6)c <0.001
Positive blood culture, n (%) 11/71 (15.5)d 10/324 (3.1)e 0.000
CSF, cerebrospinal ﬂuid.
a Deﬁned as a serum glucose level <60 mg/dl.
b Organisms identiﬁed in CSF cultures in the hypoglycorrhachia group: Streptococcus pneumoniae (n = 8), Neisseria meningitidis (n = 2), Streptococcus B (n = 1), Enterococcus
(n = 1), Haemophilus inﬂuenzae (n = 1), Cryptococcus neoformans (n = 8).
c Organisms identiﬁed in CSF cultures in the non-hypoglycorrhachia group: Streptococcus pneumoniae (n = 5), group B hemolytic streptococci (n = 1), Enterococcus (n = 1),
Staphylococcus aureus (n = 1), Listeria monocytogenes (n = 1), Haemophilus inﬂuenzae (n = 1), Cryptococcus neoformans (n = 3).
d Organisms identiﬁed in blood cultures in the hypoglycorrhachia group: Streptococcus pneumoniae (n = 7), Neisseria meningitidis (n = 1), Staphylococcus aureus (n = 1),
Cryptococcus (n = 2).
e Organisms identiﬁed in blood cultures in the non-hypoglycorrhachia group: Streptococcus pneumoniae (n = 4), group B hemolytic Streptococcus (n = 1), Streptococcus B
(n = 1), Streptococcus pyogenes (n = 1), alpha hemolytic Streptococcus (n = 1), Staphylococcus aureus (n = 1), Listeria monocytogenes (n = 1).
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signiﬁcant difference between the two groups in respect to
race, ethnicity, insurance status, or the presence of respiratory
symptoms, photophobia, fever, or seizures (p > 0.05). Patients in
the hypoglycorrhachia group complained less of headaches and
nausea, which could be due to the higher rates of altered mental
status in this group.
Hypoglycorrhachia patients had more CSF pleocytosis (median
258  106 cells/l vs. 128  106 cells/l), higher levels of CSF protein
(median 147 mg/dl vs. 71 mg/dl), and higher rates of positive CSF
and blood cultures compared to the non-hypoglycorrhachia
patients (Table 2). There was no difference in the median serum
WBC count between the two groups (p = 0.113). The median CSF
glucose was lower in the hypoglycorrhachia group (32 mg/dl)
compared to the non-hypoglycorrhachia group (58 mg/dl), but
there was no difference in the median serum glucose level between
the two groups (Table 2). There was also no case of hypoglycemia
(deﬁned as a serum glucose level <60 mg/dl) in either group.
Interestingly, only 81 of the 620 patients (13%) had concomitant
(within 60 min) CSF and serum glucose determinations performed.
A CT scan of the head was done in 66 of the 81 patients (81%) with
concomitant CSF and serum glucose compared to 525 of the
595 patients (84%) without a concomitant determination
(p > 0.05). Signiﬁcantly higher rates of positive CSF cultures
(18.7% vs. 2.6%) and positive blood cultures (15.5% vs. 3.1%) wereTable 3
Management decisions and outcomes in 620 adult patients with community-acquired 
Variable, n (%) CSF glucose <45 mg/dl
(n = 116)
CT head 107/116 (92.2) 
Abnormal head CT scan 16/107 (14.9)a
MRI of the brain 78/116 (67.3) 
Abnormal MRI of the brainc 33/78 (42.3) 
Admission to the hospital 116/116 (100) 
Empiric antibiotic therapy 79/115 (68.6) 
Empiric antiviral therapy 26/116 (22.4) 
Adverse clinical outcomed 26/116 (22.4) 
CSF, cerebrospinal ﬂuid; CT, computed tomography; MRI, magnetic resonance imaging
a Different CT abnormalities included chronic ischemic changes (n = 3), white matter ch
edema (n = 2), hydrocephalus (n = 1), pseudomeningocele (n = 1), hypodensity (n = 1), po
b Different CT abnormalities were chronic ischemic changes (n = 10), white matter ch
(n = 2), pneumocephalus (n = 1), post-operative changes (n = 1).
c MRI mass lesions, strokes, hypoattenuations, meningeal enhancement, bleeds, whi
d Glasgow outcome scale score of 1–4.found in the hypoglycorrhachia group compared to the non-
hypoglycorrhachia group (p < 0.001).
3.3. Management decisions and clinical outcomes
A CT scan of the head was done in similar proportions in the two
groups (p = 0.153), but an abnormal CT scan was found more
frequently in the hypoglycorrhachia group (14.9% (16/107) vs. 6%
(27/449); p = 0.008). Patients in the hypoglycorrhachia group were
also more likely to have an MRI of the brain ordered and to have
abnormal results (p < 0.001) (Table 3). There were no differences
between the two groups in regards to the proportion of patients
who were hospitalized or started on empiric antimicrobial therapy
(p > 0.05). An adverse clinical outcome was seen more frequently
in the hypoglycorrhachia group (22.4%) compared to the non-
hypoglycorrhachia group (8.9%) (p < 0.001).
3.4. Etiologies of hypoglycorrhachia
Urgent treatable etiologies were seen more frequently in the
hypoglycorrhachia group (58%) than in the non-hypoglycorrhachia
group (11%) (p < 0.001) (Table 4). Bacterial meningitis and
cryptococcal meningitis were seen in approximately 25% of the
hypoglycorrhachia patients each. The other etiologies associated
with hypoglycorrhachia included Mycobacterium tuberculosis, viralmeningitis with and without hypoglycorrhachia
CSF glucose >45 mg/dl
(n = 504)
p-Value
449/504 (89.0) 0.153
27/449 (6.0)b 0.008
215/504 (42.6) <0.001
77/215 (35.8) <0.001
482/503 (95.8) 0.082
375/499 (75.1) 0.328
131/500 (26.2) 0.599
45/505 (8.9) 0.000
.
anges (n = 3), infarction (n = 2), pneumocephalus (n = 2), hemorrhage (n = 2), cerebral
st-operative changes (n = 1).
anges (n = 7), mass (n = 5), hypodensity (n = 4), hemorrhage (n = 3), hydrocephalus
te matter abnormalities.
Table 4
Etiologies in 620 adult patients with community-acquired meningitis with and
without hypoglycorrhachia
Etiologies, n (%) Hypoglycorrhachia
(n = 116)
Non-
hypoglycorrhachia
(n = 504)
p-Value
Urgent treatable etiology 67/116 (57.7) 56/506 (11.1) <0.001
Bacterial meningitis 27/116 (23.2)a 16/506 (3.7)b -
Cryptococcus neoformans 26/116 (22.4) 18/506 (3.5) -
Mycobacterium tuberculosis 4/116 (3.4) 1/506 (0.2) -
Herpes simplex virus 4/116 (3.4) 9/506 (1.8) -
Varicella zoster virus 2/116 (1.7) 2/506 (0.4) -
Lymphoma/carcinomatosis 1/116 (0.9) 2/506 (0.4) -
CNS vasculitis 0/116 (0) 2/506 (0.4) -
Other bacterial infections 0/116 (0) 4/506 (0.8)c -
Miscellaneous 3/116 (2.6)d 2/506 (0.2)e -
Non-urgent treatable 6/116 (5.2) 38/506 (7.5) 0.328
Herpes simplex meningitis 5/116 (4.3) 29/506 (5.7) -
Acute HIV 1/116 (0.9) 2/506 (0.4) -
Varicella zoster virus 0/116 (0) 3/506 (0.6) -
Otherf 0/116 (0) 4/506 (0.8) -
Untreatable etiology 3/116 (2.6) 39/506 (7.7) 0.040
West Nile virus 3/116 (2.6) 25/506 (4.9) -
Enterovirus 0/116 (0) 10/506 (2.0) -
St. Louis encephalitis 0/116 (0) 3/506 (0.6) -
Epstein–Barr virus 0/116 (0) 1/506 (0.2) -
Unknown etiology 40/116 (34.6) 373/506 (73.7) <0.001
CNS, central nervous system.
a Seven different organisms were identiﬁed: Streptococcus pneumoniae (n = 20),
Streptococcus B (n = 1), Streptococcus anginosus (n = 1), Staphylococcus aureus (n = 1),
Neisseria meningitidis (n = 2), Haemophilus inﬂuenzae (n = 1), Enterococcus (n = 1).
b Nine different organisms were identiﬁed: Streptococcus pneumoniae (n = 8),
Streptococcus A (n = 1), Streptococcus B (n = 1), alpha Streptococcus (n = 1), group B
hemolytic Streptococcus (n = 1), Staphylococcus aureus (n = 1), Haemophilus inﬂuen-
zae (n = 1), Listeria monocytogenes (n = 1), Enterococcus (n = 1).
c Brucella encephalitis (n = 1), Escherichia coli urosepsis (n = 1), infective
endocarditis (n = 1), methicillin-sensitive Staphylococcus aureus brain abscess
(n = 1).
d Cytomegalovirus (n = 1), histoplasmosis (n = 1), toxoplasmosis (n = 1).
e Cerebral aneurysm (n = 1), epidural empyema (n = 1).
f Cytomegalovirus (n = 1), neurosyphilis (n = 1), inﬂuenza (n = 1), neurosarcoido-
sis (n = 1).
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zoster virus (VZV), cytomegalovirus (CMV), acute HIV infection),
histoplasmosis, toxoplasmosis, and lymphoma. Fewer patients in
the hypoglycorrhachia group had unknown etiologies compared to
the non-hypoglycorrhachia group (34.6% vs. 73.7%) (p < 0.001).Table 5
Etiologies in 116 adult patients with community-acquired meningitis with
hypoglycorrhachia
Level of hypoglycorrhachia,
CSF glucose
Etiology n (%)
<45 but 30 mg/dl 62/116 (53.4)
Unknown 31/62 (50)
Virala 14/62 (22.6)
Cryptococcus neoformans 12/62 (19.4)
Mycobacterium tuberculosis 3/62 (4.8)
Otherb 2/62 (3.2)
<30 mg/dl 54/116 (46.5)
Unknown 9/54 (16.7)
Bacterial meningitisc 27/54 (50)
Cryptococcus neoformans 14/54 (25.9)
Mycobacterium tuberculosis 1/54 (1.9)
Otherd 3/54 (5.5)
CSF, cerebrospinal ﬂuid; CNS, central nervous system.
a Herpes simplex virus (n = 9), West Nile virus (n = 3), varicella zoster virus (n = 1),
acute HIV infection (n = 1).
b Toxoplasma gondii (n = 1), Neisseria meningitidis (n = 1).
c Streptococcus pneumoniae (n = 20), Streptococcus anginosus (n = 1), Streptococcus
B (n = 1), Enterococcus (n = 1), Staphylococcus aureus (n = 1), coagulase-negative
Staphylococcus (n = 1), Haemophilus inﬂuenzae (n = 1), Neisseria meningitidis (n = 1).
d Cytomegalovirus (n = 1), Histoplasma capsulatum (n = 1), CNS lymphoma (n = 1).The hypoglycorrhachia group was further divided into two
levels of severity based on the level of CSF glucose (Table 5). The
ﬁrst category of 62 patients consisted of cases with a CSF glucose
level < 45 mg/dl but 30 mg/dl and included viral etiologies
(n = 14), Cryptococcus neoformans (n = 12), M. tuberculosis (n = 3),
Toxoplasma gondii (n = 1), and Neisseria meningitidis (n = 1). The
cause was unknown in 50% (31/62) of the cases. The second
category included 54 cases of hypoglycorrhachia levels <30 mg/dl
and included bacterial (n = 27), C. neoformans (n = 14), and one case
each of M. tuberculosis, CMV, Histoplasma capsulatum, and central
nervous system (CNS) lymphoma. The etiology was unknown in
only 16.7% (9/54) of cases.
4. Discussion
A reduction in the CSF glucose level and a change in the CSF to
serum glucose ratio are used as indicators of meningitis.1 Glucose
is mainly transported into the CSF by facilitation across the choroid
plexus and the ventricular and subarachnoid capillary system,
while some of it is transported by simple diffusion. Current
theories postulate that the pathogenesis of hypoglycorrhachia is
multifactorial and includes inhibition of glucose entry into the
subarachnoid spaces due to alterations in the blood–brain barrier,6
increased rate of glucose transport across the arachnoid villi,
increased glycolysis by leukocytes and bacteria,17 and an increased
rate of metabolism in the brain and spinal cord.
The most common cause of hypoglycorrhachia is bacterial, as
demonstrated in numerous previous studies.11,13,14,17 The present
study showed a bacterial cause of meningitis to be most common,
with up to 23% of cases being bacterial in origin. Another
signiﬁcant ﬁnding in this study was the level of hypoglycorrhachia
and positive diagnosis of an etiological agent. It was found that the
greater the hypoglycorrhachia (<30 mg/dl), the higher the
percentage of known etiologies (83.3%), and this correlates well
with the diagnostic speciﬁcity of hypoglycorrhachia in infectious
origin of meningitis. This study identiﬁed signiﬁcant ﬁndings of
comorbid conditions such as otitis media and mastoiditis, usually
with an underlying bacterial etiology. This correlation further
emphasizes that bacterial infections lead to low CSF glucose levels.
Tuberculous meningitis, although not commonly seen in the
USA, shows signiﬁcant hypoglycorrhachia, and at times this may
be the only abnormality in the CSF. There were ﬁve cases of
tuberculous meningitis in this study, and four presented with
hypoglycorrhachia. As traditional culture methods take a signiﬁ-
cant amount of time, the presence of hypoglycorrhachia with
appropriate risk exposure and chronic meningitis symptoms in the
setting of negative cultures may justify starting empiric treatment
for tuberculous meningitis. Disregarding the sole ﬁnding of
hypoglycorrhachia in potentially infected patients may lead to
missed diagnosis and a fatal outcome, with occasional establish-
ment of the diagnosis during the post-mortem examination.18
There are several case reports in the literature showing an
association between hypoglycorrhachia and aseptic meningitis
caused by HSV, CMV, VZV, and other viruses.4–7 The present study
supports the ﬁnding of hypoglycorrhachia associated with viral
causes such as HSV, VZV, and CMV.
In this study, a signiﬁcantly high number of cases of fungal
meningitis were identiﬁed, mostly cryptococcal, associated with
existing immunosuppression states such as HIV/AIDS. Patients
with cryptococcal meningitis without CSF pleocytosis due to
severe immunosuppression were excluded from the study as they
did not meet study criteria. Sporadic cases of non-infectious
etiologies of hypoglycorrhachia were observed in this study, such
as subarachnoid hemorrhage and lymphoma/carcinoma, and this
is supported by the existing literature on non-infectious causes of
hypoglycorrhachia.6–10
V. Shrikanth et al. / International Journal of Infectious Diseases 39 (2015) 39–43 43Hypoglycorrhachia is also deﬁned as a CSF to serum glucose
concentration less than 0.6. The CSF glucose level seems to be a
function of the blood glucose value that existed 30 min to 4 h prior
to the lumbar puncture.19 Under normal conditions, the CSF
glucose level reﬂects the serum glucose level. It has been suggested
that the precise interval of 30 min to 1 h between blood drawing
and lumbar puncture may yield more accurate results.10 An
attempt was made to study the relationship between CSF and
serum glucose, but unfortunately only 13% of cases had a serum
glucose done within 60 min of the lumbar puncture. This could be
explained by the high use of screening head CT scans (90%) before
lumbar puncture. However, a retrospective cross-sectional study
in children with bacterial meningitis found a linear relationship
between the levels of serum and CSF glucose.3 Nevertheless, an
isolated, clinically unexplained lowering of the CSF to serum
glucose ratio in the absence of CSF glucose <40 mg/dl should be
interpreted with caution and not overstated, as it can occur in the
absence of an appropriate neurological condition.20,21 No cases of
serum hypoglycemia contributing to the low CSF glucose levels
were found in the present study.
This study has several strengths. First, this is the ﬁrst large study
evaluating the differential diagnosis and signiﬁcance of hypogly-
corrhachia in adults presenting with community-acquired menin-
gitis. Second, this is also the ﬁrst study to document the proportion
of patients who had a CSF to serum glucose ratio performed
appropriately. Third, the data collected for all variables were
obtained at a speciﬁed ‘time zero’ at the time of initial
presentation. Lastly, the outcome deﬁnition was based on a
well-characterized outcome scale that has been used previously in
studies of bacterial meningitis.4
There are limitations to this study, despite its advantages. First,
as this study was retrospective in design, diagnostic testing was at
the discretion of the treating physician, and missing data was
inevitable. Second, although most patients who received oral
antibiotics within 2 weeks of presentation were included, a total of
32 patients who had received oral antibiotics before lumbar
puncture, were treated with intravenous antibiotics for more than
48 h, and had no identiﬁable etiology were excluded. This was
done to avoid misclassiﬁcation bias, as such patients could have
had bacterial meningitis that was partially treated with oral
antibiotics and cured with >48 h of intravenous antibiotic therapy,
yet misclassiﬁed as not having bacterial meningitis. Third, this
study included patients in the Houston area only and needs to be
generalized in other geographical areas. Lastly, the majority of the
patients (66%) had unknown causes of their meningitis.
This study clearly illustrates the prognostic signiﬁcance of
hypoglycorrhachia in community-acquired meningitis. Patients
with a low CSF glucose level were found to have more focal
neurological deﬁcits, abnormal brain imaging results, positive
cultures, urgent treatable conditions, and adverse clinical out-
comes. It was observed that only a few cases had an appropriate
serum glucose level drawn to deﬁne hypoglycorrhachia as a ratio of
the CSF to serum glucose level. This lack could be due to the need
for CT imaging of the head done prior to the lumbar puncture.Hence, it is reasonable to conclude that deﬁning hypoglycor-
rhachia as a single numerical entity is more feasible than as a ratio
in our current practice.
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